Shocker! Eric Dane leaving 'Grey's Anatomy'

Grey's Anatomy fans will have to say goodbye to McSteamy! The infamous Mark Sloan, played by actor Eric Dane, is reportedly leaving the hit ABC series, much to the dismay of female fans everywhere.

We last saw Sloan in a hospital bed close to death at the end of season 8 and, although creator Shonda Rhimes hints that this isn't the last we are going to see of the dreamy doc, a statement from Dane himself proves otherwise.

"I am extremely grateful to everyone at Grey's , ABC and Shondaland for the experience and memories I have had over the course of this run. It has been wonderful to work alongside and learn from a creative force such as Shonda Rhimes," Dane says in a statement to TV Line.

At the end of season 8, Dane's character was clinging to life after a horrible plane crash that killed his love, Lexie (Chyler Leigh). E! Online spoke with Rhimes after the finale, who said, "They're still out there in the forest, and we don't know if they are going to be OK," she teased. "We left it open for a reason becauseI hate to say this, but just because you saw people alive at the end of the finale doesn't mean they're going to be alive when the season starts up. We are completely jumping off into the unknown next season."

Rhimes also claims that Dane's decision to leave the show was a tough one. As "one of the most beloved characters on the show," Dane had many conversations with Rhimes before they finally decided that it was time for McSteamy's story line to end.

The ninth season of Grey's Anatomy begins Sept. 27 on ABC. We can only imagine what will happen this season!

INFDaily

Follow this link:
Shocker! Eric Dane leaving 'Grey's Anatomy'

‘Grey’s Anatomy’ Shocker: Eric Dane Announces His Departure

072612_mark_sloan_featuredDr. Sloan will make his final rounds this fall! Are you devastated?

Greys Anatomy is seriously losing steam well, McSteamy, to be exact. HollywoodLife.coms sister site TV Line is reporting that Eric Dane is checking out of the hit ABC medical drama after more than six clothing-optional seasons. But there is some good news: Dr. Mark Sloan will return to Seattle Grace at the beginning of season nine to wrap up his story line.

I am extremely grateful to everyone at Greys, ABC and Shondaland for the experience and memories I have had over the course of this run, Eric tells the site. It has been wonderful to work alongside and learn from a creative force such as Shonda Rhimes.

Shonda also spoke to the site, clarifying that Erics exit was a decision they came to together.

Personally, I cant say Im too surprised to see him leave. When Lexie (Chyler Leigh) died on the eighth season finale, Sloan was devastated not to mention he was suddenly without a love interest. (And whats the use of Sloan if he isnt plowing someone in the break room?)

But rather than focus on the sad news of Sloans departure, lets remember the good times and by that, I mean the doctors first appearance during the second season finale. (That towel should have been credited as a special guest star. For real.)

Click here to view the embedded video.

Are you devastated by this news, Greys fans? Or do you agree with me that its the right for Sloan to complete his rounds? Drop me a comment with your reaction to this life-changing news.

More Greys Anatomy News:

Get more from Hollywoodlife.com: Follow us on Twitter, Facebook, Newsletter

Read this article:
‘Grey’s Anatomy’ Shocker: Eric Dane Announces His Departure

Eric Dane Announces Exit From 'Grey's Anatomy'

Grey's Anatomy's Eric Dane, aka Dr. McSteamy, is taking his leave from Seattle Grace.

"I am extremely grateful to everyone at Grey's, ABC and Shondaland for the experience and memories I have had over the course of this run," said Dane in a statement to TVLine. "It has been wonderful to work alongside and learn from a creative force such as Shonda Rhimes."

RELATED: Eric Dane & Rebecca Gayheart Safe after Tree Crashes into Home

Dane, who joined the show in 2006, is said to be leaving Grey's to pursue other opportunities.

Rhimes, the series' creator, responded to Dane's announcement with a statement of her own, calling McSteamy "one of the most beloved characters on Grey's Anatomy," adding that Dane "did not come to this decision lightly, but after much consideration and conversations, he and I have decided that this is the right time for his storyline to end. We're a big family here at Grey's with a long history together and Eric will always remain an important part of our family. I wish him the best and I look forward to watching him as he continues to steam up the big and small screen."

'Grey's Anatomy' Star Sara Ramirez Gets Married

No word yet as to how Dane's storyline will end. In last season's dramatic finale, his character Dr. Mark Sloan lost his lover Lexie (Chyler Leigh) in a devastating plane crash.

Season nine of Grey's Anatomy comes to ABC Thursday, September 27.

Continued here:
Eric Dane Announces Exit From 'Grey's Anatomy'

Harvard gets $37M to develop ‘human-on-a-chip’ tech

Courtesy Wyss Institute

Wyss Institute researchers and a multidisciplinary team of collaborators seek to build and link 10 human organs-on-chips to mimic whole body physiology. The system will incorporate the Institutes Human Gut-on-a-Chip (seen here).

Harvards Wyss Institute for Biologically Inspired Engineering at Harvard University announced recently it will receive $37 million from the Defense Advanced Research Projects Agency to develop technology that studies the human physiology.

The five-year project will be led by Wyss Founding Director, Donald Ingber, M.D., Ph.D. and Wyss faculty member, Kevin Kit Parker, Ph.D. in conjunction with Wyss researchers and a multidisciplinary team of collaborators, a statement reads.

The project will develop an automated instrument that integrates 10, organs-on-chips to study complex human physiology outside the body.

Serving as an alternative to traditional animal testing models that often fail to predict human responses, the automated instrument will be used to rapidly assess responses to new drug candidates, providing critical information on their safety and efficacy, according to the release.

Equal in size to a computer memory stick, each individual chip is composed of a clear flexible polymer that contains hollow microfluidic channels lined by living human cells.

Because of the translucency of the microdevices, researchers have a window into the inner-workings of human organs without having to invade a living body.

The goal is to shorten the time and cost it takes to develop drugs, and more importantly, to increase the likelihood of success when the drug finally is tested in humans currently it is less than 15 percent success, even after many years and hundreds of millions to billions investment, Ingber wrote in an email to Mass High Tech.

In a statement, Jesse Goodman, Food and Drug Administration chief scientist and deputy commissioner for science and public health, said the automated human-on-chip instrument being developed has the potential to be a better model for determining human adverse responses. FDA looks forward to working with the Wyss Institute in its development of this model that may ultimately be used in therapeutic development.

Originally posted here:
Harvard gets $37M to develop 'human-on-a-chip' tech

Research and Markets: An Atlas of Hair Pathology with Clinical Correlations

DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/pbmth2/an_atlas_of_hair_p) has announced the addition of the "An Atlas of Hair Pathology with Clinical Correlations" book to their offering.

This new edition keeps an acclaimed text at the forefront of the market. Diagnosing and treating hair disorders is still a subject that is rarely or only superficially covered in residency training, so dermatopathologists and clinical dermatologists often find a gap in their knowledge; this new edition bridges that gap by serving as a primer, an atlas, and a reference.

As a primer it supplies the basic information on anatomy and details the practical processes of evaluating specimens.

As an atlas it is rich in new photographs demonstrating basic and advanced histologic features of hair disease, with several new diagnoses included.

As a reference it includes the latest information and an augmented guide to the basic clinical features that provide a clinical / pathological correlation.

Topics Covered:

- Using this book.

- Specimen Acquisition, Handling, and Processing.

- Normal Hair Anatomy and Architecture.

More here:
Research and Markets: An Atlas of Hair Pathology with Clinical Correlations

Wockhardt closes nutrition business sale to Danone

Litigation shadow off Rs 1,280-cr deal

Mumbai, July 26:

The uncertainty over drug maker Wockhardts sale of its nutrition business to Danone has ended.

The company has closed the Rs 1,280-crore transaction, Wockhardt said on Thursday.

Despite the deal with Danone being formalised last August, Wockhardt had some heart-stopping moments, as litigation involving its unhappy bond-holders cast its shadow on this deal as well.

An attempt in 2009 by Wockhardt to sell its nutrition business to Abbott fell through precisely for that reason Wockhardt was unable to resolve debt restructuring issues with some of its lenders.

The Abbott deal was for Rs 600 crore. But Wockhardt sealed the Danone deal at Rs 1,600 crore.

Of this amount, about Rs 640 crore would go to Wockhardt Ltd, and an equal amount to Wockhardt EU, and Rs 320 crore to Carol Info Services, a source familiar with the deal said.

But worries over the Danone deal increased as the March 2012 timeline to seal the deal, mentioned by Wockhardt Executive Chairman Dr Habil Khorakiwala, also lapsed.

Debt-saddled Wockhardt had started exiting non-core businesses after it hit the hard times in 2008.

View original post here:
Wockhardt closes nutrition business sale to Danone

New Products from Creative Edge Nutrition, SDN Brand Help Athletes Improve Pre-Workout and Energy To Meet Fitness Goals

MADISON HEIGHTS, Mich., July 26, 2012 /PRNewswire/ -- Creative Edge Nutrition, Inc. (FITX), a nutritional supplement company focusing on active lifestyles, announced today that their Brand, Science Defined Nutrition http://www.sciencedefinednutrition.com, which Athletes demand for nutritional needs beyond a normal diet, has formulated, designed anddeveloped 3 new products for exercise enthusiasts for building muscle and energy as a main objective. All products are Developed By & Exclusively Manufactured in the USA For Creative Edge Nutrition, Inc.

New Science Defined Nutrition Products:

Bill Chaaban, President and CEO, stated, "We are excited to introduce the new products along with exclusive new ingredients it will allow Creative Edge Nutrition a leg up on the competition. The benefits of well-timed proper nutrition can reduced muscle fatigue as well as accelerate repair. We will continue to aggressively grow and expand our presence in the sports nutrition marketplace through both organic growth and strategic acquisitions."

About Creative Edge Nutrition, Inc.

Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. http://www.CenergyNutrition.com and http://www.facebook.com/pages/Creative-Edge-Nutrition-Inc/115224738609211

About Science Defined Nutrition, Inc.

Developed by body builders and athletes, Science Defined Nutrition (SDN) is a leader in nutritional supplement industry. SDN's Research and Development Team has cultivated an entire litany of superlative products, with the initial proof-providing ground-breaking product ROGUE at the helm, rooted in the immeasurable passion for achieving athletic enhancement through tireless scientific scrutiny. The core Mission of SDN is to assist our customers in taking their athletic ambitions to heights unknown, without having to defy their own conscience by sacrificing their state of health to do so. http://www.sciencedefinednutrition.com

Safe Harbor Notice This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

Contact: Paul Thomas (313) 655-1669 Email: Info@cenergynutrition.com

The rest is here:
New Products from Creative Edge Nutrition, SDN Brand Help Athletes Improve Pre-Workout and Energy To Meet Fitness Goals

New Pall GeneDisc® System For Rapid Microbiological Monitoring Solution In Beer Production

PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--

Pall Corporation (NYSE: PLL) announced today that it has launched a quick, easy and affordable test for beer-spoilage microorganisms based on its GeneDisc Rapid Microbiology System.

Utilizing real-time Polymerase Chain Reaction (PCR) technology, Palls GeneDisc test provides a fast, reliable and user-friendly detection method to identify typical bacteria that are known to spoil beer. The system yields consistently repeatable results and virtually eliminates operator error. Test results from a beer sample are available after enrichment and DNA isolation within one hour.

"For the first time, the benefits of PCR technology are available to brewers for routine, day-to-day use, said Jonathan Pratt, president, Pall Food and Beverage. The new GeneDisc system offers breweries an extremely easy-to-use and rapid test method to better ensure that products at every stage of the production process are free of spoilage organisms."

The Pall GeneDisc system features an exceptionally robust PCR platform combined with ready-to-use GeneDisc test plates. Using the GeneDisc plate for beer-spoilage bacteria, the system simultaneously screens for the presence or absence of 20 critical beer-spoilage bacteria, including the relevant species of Lactobacillus, Megasphaera, Pediococcus and Pectinatus sp. beer-spoilage groups.

With its intuitive touch-screen interface, built-in software and barcode reader, the system enables minimally trained personnel to routinely perform sophisticated biological sample testing for rapid decision-making. The flexible GeneDisc system also helps optimize work flow and offers the capability to process multiple samples simultaneously.

Learn more about the GeneDisc Rapid Microbiology System and the Beer Spoilage Plate at the World Brewing Congress, an international gathering of brewing industry professionals, July 28-31, 2012 in Portland, Oregon, booth # 855.

About Pall Food and Beverage

Pall Food and Beverage serves the food and beverage industries with advanced membrane filtration technology and systems engineered for reliability and cost-effectiveness. Innovative filters, which are easy to install and simple to use, allow a cost-effective and well-controlled process operation. Visit us on the Web at http://www.pall.com/foodandbev.asp.

About Pall Corporation

Excerpt from:
New Pall GeneDisc® System For Rapid Microbiological Monitoring Solution In Beer Production

BioMed Diagnostics’ Microbiology Diagnostic Devices Now Available Worldwide Through Distribution Agreement With VWR …

WHITE CITY, Ore., July 26, 2012 /PRNewswire/ -- BioMed Diagnostics, Inc., an innovative manufacturer of microbiology devices that facilitate and enhance infectious disease diagnosis, today announced its patented InTray and InPouch product lines will now be available worldwide through a new agreement with VWR International, LLC, a global laboratory supply and distribution company with 2011 worldwide sales in excess of $4.1 billion. Under the terms of the agreement, VWR will distribute BioMed's products for the diagnosis of infectious disease.

InTray and InPouch devices uniquely combine sample collection, transport, and culture in a single read-out ready platform, thereby reducing handling, increasing productivity, improving throughput and reducing the risk of sample exposure and contamination.

"The productivity and accuracy advantages of InTray and InPouch have won these tests a growing customer base over the past few years. We are delighted that distribution leader VWR will now extend our reach to its extensive customer base so more healthcare providers around the globe will have access to these unique products," said Jim Self, Chief Executive Officer of BioMed Diagnostics.

"BioMed's one-step collection, transport, incubation and observation devices are a simple yet elegant solution for point-of-care infectious disease diagnosis," noted Steve Goodman, Senior Vice President of Category Management for VWR. "The initial response to these products has been excellent and we look forward to making them available globally to the many labs and facilities that can benefit from their use."

BioMed's InPouch product is an easy-to-use, fully enclosed oxygen-resistant plastic pouch for microbiology sample collection, transport, culture and observation. Once the sample has been inoculated, the InPouch is sealed against contamination. The optically clear InPouch can be directly viewed under the microscope without the need to prepare a wet mount slide. InPouch offers a variety of proprietary media that deliver high specificity and selectivity and has a long shelf life of up to one year. InPouch is also compatible for use with PCR.

BioMed's InTray product is a fully enclosed cassette for microbiology sample collection, transport and culture. This stackable device can be observed under a microscope through optically clear plastic, eliminating the need to prepare a wet mount slide. The fully enclosed system features controlled air exchange to protect against exposure or contamination, and is ideal for field use or austere environments. InTray products featuring proprietary Colorex technology produce easy-to-interpret results that can be read visually via color changes in the sample.

For more information, visit http://www.biomeddiagnostics.com/clinical.

About BioMed Diagnostics BioMed Diagnostics, Inc. is a manufacturer of in vitro clinical diagnostic, veterinary, environmental and research-only microbiology testing devices that save time and money, improve workflow and throughput, and reduce sample exposure and contamination. By combining sample collection, transport and culture in a single read-out ready platform, BioMed's InPouch and InTray devices help medical professionals, veterinarians, researchers and environmental and industry scientists accurately detect and enumerate a variety of bacterial and fungal pathogens. The devices' unique sealed design reduces the risk of pathogen exposure, and they have a long shelf life. InTray products featuring Colorex technology enable easy-to-interpret visual results from a simple color change. To learn more about BioMed Diagnostics products and services, visit:www.biomeddiagnostics.com.

Link:
BioMed Diagnostics' Microbiology Diagnostic Devices Now Available Worldwide Through Distribution Agreement With VWR ...

Japan's women lose longevity title

Japanese women are no longer the world's longest living, their longevity pushed down in part by last year's devastating earthquake and tsunami, according to a government report.

The annual report by Japan's health ministry said the expected lifespan for Japanese women slipped to 85.90 years in 2011 from 86.30 the year before, mainly due to disease and other natural causes of death. The result is that Hong Kong women now find themselves at the top of the world life expectancy rankings. The life expectancy for Japanese men also declined slightly, from 79.55 to 79.44.

The report said that the earthquake and tsunami, which killed nearly 20,000 people, contributed to pushing the statistics down.

It noted that if deaths related to the disaster were not included, the life expectancies would be higher for both men, at 79.70 years, and women, at 86.24.

But the official life expectancy for women in Hong Kong 86.70 years in 2011 would still be longer than Japan's even without the disaster deaths, the report said.

It said suicides among Japanese women have been on the rise, and that was a contributing factor, although disease and other natural causes remained the most important issues.

View original post here:
Japan's women lose longevity title

DNA damage in roofers due to PAH exposure, possible cancer link

ScienceDaily (July 26, 2012) Roofers and road construction workers who use hot asphalt are exposed to high levels of polycyclic aromatic hydrocarbons (PAHs). A University of Colorado Cancer Center study published this week in the British Medical Journal Open shows that roofers have higher PAH blood-levels after working a shift and that these high levels of PAHs are linked with increased rates of DNA damage, and potentially with higher cancer risk.

"We've known for some time that roofers and road workers have higher cancer rates than the general population, but we also know roofers have a higher rates of smoking, alcohol use and higher UV exposure than the general population. It's been difficult to pinpoint the cause of higher cancer rates -- is it due to higher PAHs or is it due to lifestyle and other risk factors?" says Berrin Serdar, MD, PhD, investigator at the CU Cancer Center and assistant professor of environmental and occupational health at the Colorado School of Public Health.

Her study, completed with colleagues at the University of Miami, studied 19 roofers from four work sites in Miami-Dade County. Participants' urine samples, provided before and after a 6-hour shift, showed that after acute exposure to hot asphalt, PAH biomarkers were elevated. Overall, biomarkers of PAH exposure and oxidative DNA damage (8-OHdG) were highest among workers who didn't use protective gloves and workers who also reported work related skin burns, pointing to the role of PAH absorption through skin.

"PAHs are a complex mixture of chemicals some of which are known human carcinogens. They are produced by incomplete combustion of organic materials and exist in tobacco smoke, engine exhaust, or can come from environmental sources like forest fires, but the highest exposure is among occupational groups, for example coke oven workers or workers who use hot asphalt," Serdar says.

"We can't say with certainty that exposure to hot asphalt causes roofers' increased cancer rate," Serdar says, "but that possibility is becoming increasingly likely. Hot asphalt leads to PAH exposure, leads to higher PAH biomarkers, leads to increased DNA damage -- we hope to further explore the final link between DNA damage due to PAH exposure and higher cancer rates in this population."

Serdar and colleagues at the CU Cancer Center have initiated a wider study of roofers in the Denver metropolitan area. This study will simultaneously investigate air, blood, and urine levels of PAHs and their link to DNA damage in samples collected over a workweek.

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

Story Source:

The above story is reprinted from materials provided by University of Colorado Denver. The original article was written by Garth Sundem.

More here:
DNA damage in roofers due to PAH exposure, possible cancer link

Posted in DNA

DNA tests in new Michaela inquiry

26 July 2012 Last updated at 03:59 ET

Police in Mauritius have begun DNA testing of hotel staff working on the day Michaela McAreavey was murdered.

Detectives are at the former Legends hotel to collect samples from 216 employees.

These will be compared with traces left at the scene of the honeymoon suite where the 27-year-old from County Tyrone was killed in January 2011.

A new investigation team was set up after two former hotel workers were acquitted of murder earlier this month.

The BBC's Yasine Mohabuth said detectives were also taking fingerprints "for comparison with those found at the scene of crime".

Hotel director Brice Lunot told independent station Radio Plus: "The hotel management is relieved at the decision to reopen the investigation."

Mauritius foreign affairs minister, Arvin Boolell, has promised that "no stone will be left unturned" until these responsible for Mrs McAreavey's death were found.

Former hotel workers Sandip Moneea and Avinash Treebhoowoon were cleared of Mrs McAreavey's killing by a jury at the Supreme Court in the capital Port Louis.

View post:
DNA tests in new Michaela inquiry

Posted in DNA

Neanderthal-type species once roamed Africa, DNA shows

The human family tree just got another mysterious branch, an African sister species to the heavy-browed Neanderthals that once roamed Europe.

While no fossilized bones have been found from these enigmatic people, they did leave a calling card in present-day Africans: snippets of foreign DNA.

Theres only one way that genetic material could have made it into modern human populations.

Geneticists like euphemisms, but were talking about sex, said Joshua Akey of the University of Washington in Seattle, whose lab identified the mystery DNA in three groups of modern Africans.

These genetic leftovers do not resemble DNA from any modern-day humans. The foreign DNA also does not resemble Neanderthal DNA, which shows up in the DNA of some modern-day Europeans, Akey said. That means the newly identified DNA came from an unknown group.

Were calling this a Neanderthal sibling species in Africa, Akey said. He added that the interbreeding probably occurred 20,000 to 50,000 years ago, long after some modern humans had walked out of Africa to colonize Asia and Europe, and around the same time Neanderthals were waning in Europe.

The find offers more evidence that for thousands of years, modern-looking humans shared the Earth with evolutionary cousins who later died out. And whenever the groups met, whether in Africa or Europe, they did what came naturally they bred. In fact, hominid hanky-panky seems to have occurred wherever humans met others who looked kind of like them a controversial idea until recently.

In 2010, researchers from the Max Planck Institute for Evolutionary Anthropology in Germany announced finding Neanderthal DNA in the genomes of modern Europeans.

Barrel-chested people whose thick double brows, broad noses and flat faces set them apart from modern humans, Neanderthals disappeared around 25,000 to 30,000 years ago.

Another mysterious group of extinct people recently identified from a 30,000-year-old finger bone in Siberia known as the Denisovans also left some of their DNA in modern-day Pacific Islanders.

Read more:
Neanderthal-type species once roamed Africa, DNA shows

Posted in DNA

Federal appeals court to reconsider California DNA-collection law

A federal appeals court will take a second look at a California law that requires police to collect DNA from people who are arrested on suspicion of felonies, regardless of whether they are convicted.

A majority of judges on the U.S. 9th Circuit Court of Appeals voted Wednesday to reconsider a split decision by a three-judge panel that had upheld the program in February.

The court's decision to ask an 11-judge panel to consider the case was a setback for prosecutors, who have defended the DNA collection as a vital crime-fighting tool.

Once a person is swabbed, his or her DNA profile is placed in a criminal database, where it can be compared with DNA profiles obtained from evidence left at crime scenes. Among those challenging the program were three protesters who were arrested but never convicted of a crime. Two of those challengers were released without being charged.

California voters approved collecting DNA from felony arrestees in 2004, passing Proposition 69 by a wide margin. The state began taking DNA from people arrested on suspicion of felonies in 2009 but immediately faced litigation over whether the collection violated the constitutional rights of people to be free of unreasonable searches and seizures.

In his dissent in February, 9th Circuit Judge William A. Fletcher questioned the effectiveness of the program, observing that many DNA "hits" to crime scene evidence involved suspects who were eventually convicted. The state has long obtained DNA from convicted criminals, a practice courts have upheld.

Although people who are not convicted may apply to have their DNA profile removed from the criminal database, "expungement is a lengthy, uncertain, and expensive process," Fletcher wrote.

The California Supreme Court also is examining the legality of collecting genetic evidence from people before conviction, after a lower state court ruled the practice unconstitutional.

Atty. Gen.Kamala D. Harris, whose office is defending the DNA program, has said that the arrestee DNA collection has solved thousands of crimes. Her office said the potential genetic matches to crime scene evidence rose nearly 51% in the year after authorities began compiling arrestee DNA.

Most states take DNA from at least some felony suspects before conviction, but courts have been split over the constitutionality of the practice. TheU.S. Supreme Courtis considering a ruling out of Maryland that struck down that state's collection of DNA from people never convicted of a crime.

The rest is here:
Federal appeals court to reconsider California DNA-collection law

Posted in DNA

Proteostasis Therapeutics Announces Expansion of Collaboration with The Scripps Research Institute to Broaden Cystic …

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with neurodegenerative and orphan diseases, announced today that it has expanded its collaboration with The Scripps Research Institute (TSRI) to encompass an additional funded research project focused on biology and the testing of small molecule modulators of protein folding and trafficking for the treatment of cystic fibrosis (CF). This expansion follows the Companys recently announced collaboration with the Cystic Fibrosis Foundation to research, develop, and commercialize therapies to treat patients with the most common mutation of the cystic fibrosis transmembrane conductance regulator (CFTR), Delta F508.

This expanded collaboration will allow us to accelerate our CF program as we work to advance our most promising series to lead optimization this year, said Mark Enyedy, Chief Executive Officer of Proteostasis Therapeutics.

Working with the laboratory of William Balch, Ph.D., Professor of Cell Biology at TSRI, scientists at Proteostasis Therapeutics have used an integrated platform comprised of genomics, proteomics, functional assays, and medicinal chemistry to identify compounds that regulate key folding and trafficking pathways in the cell. To date, these compounds have demonstrated significant efficacy in CF-specific cellular models. Under the expanded collaboration, Proteostasis Therapeutics will provide funding for this research and will have exclusive rights to license any technology originating from the research.

We are excited to deepen our relationship with Proteostasis Therapeutics to develop novel approaches that manage the root cause of the problem of this devastating disease, added Dr. Balch.

This newly expanded collaboration will enhance the ability of Proteostasis Therapeutics to perform chaperone-based high throughput screening in multiple disease relevant cellular models to identify Proteostasis Regulators that will correct the folding, trafficking and function of Delta F508 CFTR, both alone and in combination with agents currently in development or on the market.

Dr. Balchs expertise in CF biology and protein homeostasis complements our proprietary technology for characterizing proteostasis network pathways in normal and disease states. The expansion of this collaboration further underscores our commitment to working with leading academic scientists and institutions in our focus areas in neurodegenerative and orphan diseases, stated Peter Reinhart, Chief Scientific Officer of Proteostasis Therapeutics.

About The Scripps Research Institute

The Scripps Research Institute is one of the world's largest independent, not-for-profit organizations focusing on research in the biomedical sciences. Over the past decades, Scripps Research has developed a lengthy track record of major contributions to science and health, including laying the foundation for new treatments for cancer, rheumatoid arthritis, hemophilia, and other diseases. The institute employs about 3,000 people on its campuses in La Jolla, CA, and Jupiter, FL, where its renowned scientistsincluding three Nobel laureateswork toward their next discoveries. The institute's graduate program, which awards Ph.D. degrees in biology and chemistry, ranks among the top ten of its kind in the nation. For more information, see http://www.scripps.edu.

About Proteostasis Therapeutics

Continue reading here:
Proteostasis Therapeutics Announces Expansion of Collaboration with The Scripps Research Institute to Broaden Cystic ...

Science magazine prize goes to virtual world where undergrads explore DNA

Public release date: 26-Jul-2012 [ | E-mail | Share ]

Contact: Natasha Pinol npinol@aaas.org 202-326-6440 American Association for the Advancement of Science

When Brian White was a child, his kindergarten teacher wrote in his student record that he would only talk to the other children if the topic was science. Throughout his childhood, White's fascination with science led him to take batteries apart, blow things up, and to build radios and computer components.

Now an associate professor in the biology department at the University of Massachusetts, Boston, White is the winner of the Science Prize for Inquiry-Based Instruction (IBI). He won the award for his creation of Aipotu, a computer-simulated world in which students apply the tools of genetics, biochemistry, molecular biology and evolution to develop an understanding of the formation of color in a flower.

"What I'm trying to do is give people the tools to play around," says White, who explains that Aipotu is "utopia" backward. "What I've always liked about science is what you could do with what you learned."

Science's IBI Prize was developed to showcase outstanding materials, usable in a wide range of schools and settings, for teaching introductory science courses at the college level. The materials must be designed to encourage students' natural curiosity about how the world works, rather than to deliver facts and principles about what scientists have already discovered. Organized as one free-standing "module," the materials should offer real understanding of the nature of science, as well as providing an experience in generating and evaluating scientific evidence. Each month, Science publishes an essay by a recipient of the award, which explains the winning project. The essay about Aipotu will be published on July 27.

"We're trying to advance science education," says Bruce Alberts, editor-in-chief of Science. "This competition provides much-needed recognition to innovators in the field whose efforts promise significant benefits for students and for science literacy in general. The publication in Science of an article on each laboratory module will help guide educators around the globe to valuable free resources that might otherwise be missed."

After many hours of experiments in his parents' basement, White went on to MIT for his undergraduate work. Many of his classes were lectures, but by his junior year, he was able to take a class that had him in the lab all afternoon every day.

"I cooked up many harebrained experiments," White says. "In the lab, you learn problem-solving. Most of the time, what you attempt doesn't work, so you have to figure out why."

Throughout his education, White had some wonderful teaching experiences, he says, including at a science camp in Woods Hole, Massachusetts, where one of his students built a pinball machine that kept score. White said demonstrating the machine to the student's parents was an amazing moment, one of many that White had early on that drew him into education.

Read the original post:
Science magazine prize goes to virtual world where undergrads explore DNA

‘Grey’s Anatomy’ Shocker: Eric Dane Announces His Departure

072612_mark_sloan_featuredDr. Sloan will make his final rounds this fall! Are you devastated?

Greys Anatomy is seriously losing steam well, McSteamy, to be exact. HollywoodLife.coms sister site TV Line is reporting that Eric Dane is checking out of the hit ABC medical drama after more than six clothing-optional seasons. But there is some good news: Dr. Mark Sloan will return to Seattle Grace at the beginning of season nine to wrap up his story line.

I am extremely grateful to everyone at Greys, ABC and Shondaland for the experience and memories I have had over the course of this run, Eric tells the site. It has been wonderful to work alongside and learn from a creative force such as Shonda Rhimes.

Shonda also spoke to the site, clarifying that Erics exit was a decision they came to together.

Personally, I cant say Im too surprised to see him leave. When Lexie (Chyler Leigh) died on the eighth season finale, Sloan was devastated not to mention he was suddenly without a love interest. (And whats the use of Sloan if he isnt plowing someone in the break room?)

But rather than focus on the sad news of Sloans departure, lets remember the good times and by that, I mean the doctors first appearance during the second season finale. (That towel should have been credited as a special guest star. For real.)

Click here to view the embedded video.

Are you devastated by this news, Greys fans? Or do you agree with me that its the right for Sloan to complete his rounds? Drop me a comment with your reaction to this life-changing news.

More Greys Anatomy News:

Get more from Hollywoodlife.com: Follow us on Twitter, Facebook, Newsletter

Go here to see the original:
‘Grey’s Anatomy’ Shocker: Eric Dane Announces His Departure

Eric Dane Announces Exit From 'Grey's Anatomy'

Grey's Anatomy's Eric Dane, aka Dr. McSteamy, is taking his leave from Seattle Grace.

"I am extremely grateful to everyone at Grey's, ABC and Shondaland for the experience and memories I have had over the course of this run," said Dane in a statement to TVLine. "It has been wonderful to work alongside and learn from a creative force such as Shonda Rhimes."

RELATED: Eric Dane & Rebecca Gayheart Safe after Tree Crashes into Home

Dane, who joined the show in 2006, is said to be leaving Grey's to pursue other opportunities.

Rhimes, the series' creator, responded to Dane's announcement with a statement of her own, calling McSteamy "one of the most beloved characters on Grey's Anatomy," adding that Dane "did not come to this decision lightly, but after much consideration and conversations, he and I have decided that this is the right time for his storyline to end. We're a big family here at Grey's with a long history together and Eric will always remain an important part of our family. I wish him the best and I look forward to watching him as he continues to steam up the big and small screen."

'Grey's Anatomy' Star Sara Ramirez Gets Married

No word yet as to how Dane's storyline will end. In last season's dramatic finale, his character Dr. Mark Sloan lost his lover Lexie (Chyler Leigh) in a devastating plane crash.

Season nine of Grey's Anatomy comes to ABC Thursday, September 27.

See original here:
Eric Dane Announces Exit From 'Grey's Anatomy'

New Vacation Memory Keepsake Introduced by YourCover

Vacation memories live on with the new YourCover World Travel and Family Vacation magazine cover template designs. Plus new print sizes make magazine cover gifts easier to frame and give.Wilton, CT (PRWEB) July 26, 2012 YourCover has been offering personalized magazine covers since 2000 but is continually updating and offering new themes, titles and ideas to satisfy customer needs. Two new ...

See original here:

New Vacation Memory Keepsake Introduced by YourCover

Explore My World Travel Reveals Secret to Staying Safe at London Olympics

With the London Olympic Games kicking off at the end of the week, and officials insisting that Olympic security will not be compromised despite the shambles surrounding a private contractor’s failure to provide sufficient guards, visitors are left wondering how safe the London Olympics will be. Victoria Ugarte, founder of Explore My World Travel, reveals the secret to staying safe at the London ...

Original post:

Explore My World Travel Reveals Secret to Staying Safe at London Olympics